Cold Agglutinin Disease
Immunology·MeSH: Anemia, Hemolytic, Autoimmune
Prevalence
0.5 / 100K
3 drugs in development·3 companies·2 clinical trials
Drug Pipeline by Phase
Phase 3(2)
Phase 1(1)
| Drug | Company |
|---|---|
| ANX1502 | Annexon, Inc. (ANNX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Cold Agglutinin Disease?
BioSniper tracks 3 drugs in development for Cold Agglutinin Disease across 3 companies.
How many clinical trials target Cold Agglutinin Disease?
There are 2 clinical trials targeting Cold Agglutinin Disease tracked by BioSniper.
What is the prevalence of Cold Agglutinin Disease?
The estimated prevalence of Cold Agglutinin Disease is approximately 0.5 per 100,000 population.
Deep-dive into Cold Agglutinin Disease
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis